
Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC: Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
moreShow OMIC Financials
Recent trades of OMIC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by OMIC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods and systems for multidimensional imaging Aug. 01, 2023
-
Patent Title: Silicon containing detectable compounds Jul. 11, 2023
-
Patent Title: Systems and methods for multicolor imaging Jun. 27, 2023
-
Patent Title: Spatial sequencing Jun. 20, 2023
-
Patent Title: High density sequencing and multiplexed priming May. 16, 2023
-
Patent Title: Methods for in situ transcriptomics and proteomics May. 09, 2023
-
Patent Title: Nanoarrays and methods of use thereof Apr. 18, 2023
-
Patent Title: Flow cell carrier Apr. 11, 2023
-
Patent Title: Sample cartridge Mar. 21, 2023
-
Patent Title: Nucleic acid sequencing-by-synthesis (sbs) methods that combine sbs cycle steps Feb. 28, 2023
-
Patent Title: Reagent cartridge Feb. 21, 2023
-
Patent Title: High density sequencing and multiplexed priming Feb. 14, 2023
-
Patent Title: Methods and compositions for sequencing complementary polynucleotides Jan. 24, 2023
-
Patent Title: Silicon containing detectable compounds and uses thereof Dec. 27, 2022
-
Patent Title: Linked paired strand sequencing Dec. 06, 2022
-
Patent Title: Modified thermoccocus polymerases Nov. 29, 2022
-
Patent Title: Wash bottle Nov. 22, 2022
-
Patent Title: Flow cell receiver and methods of use Nov. 15, 2022
-
Patent Title: Reagent cartridge Nov. 15, 2022
-
Patent Title: Methods for in situ transcriptomics and proteomics Nov. 08, 2022
-
Patent Title: Methods of sequencing circular template polynucleotides Nov. 01, 2022
-
Patent Title: Methods and compositions for sequencing complementary polynucleotides Nov. 01, 2022
-
Patent Title: Spatial sequencing Sep. 06, 2022
-
Patent Title: Systems and methods for multicolor imaging Aug. 16, 2022
-
Patent Title: Linked paired strand sequencing Jun. 21, 2022
-
Patent Title: Compositions and methods for nucleic acid sequencing Feb. 01, 2022
-
Patent Title: Methods for long read sequencing Jan. 18, 2022
-
Patent Title: Modified nucleotides and uses thereof Nov. 16, 2021
-
Patent Title: Polynucleotide barcodes for long read sequencing Oct. 26, 2021
-
Patent Title: Modified archaeal family b polymerases Oct. 05, 2021
-
Patent Title: Modified pyrococcus polymerases and uses thereof Jun. 15, 2021
-
Patent Title: Devices, systems, and methods for single molecule, real-time nucleic acid sequencing Mar. 23, 2021
-
Patent Title: Nucleotide cleavable linkers and uses thereof Nov. 03, 2020
-
Patent Title: Nucleotide analogues Aug. 11, 2020
Federal grants, loans, and purchases
Followers on OMIC's company Twitter account
Number of mentions of OMIC in WallStreetBets Daily Discussion
Recent insights relating to OMIC
Recent picks made for OMIC stock on CNBC
ETFs with the largest estimated holdings in OMIC
Flights by private jets registered to OMIC